Free Trial

Absci (ABSI) Stock Price, News & Analysis

$4.96
+0.45 (+9.98%)
(As of 06/12/2024 ET)
Today's Range
$4.63
$4.98
50-Day Range
$4.18
$6.59
52-Week Range
$1.11
$6.72
Volume
1.46 million shs
Average Volume
1.34 million shs
Market Capitalization
$560.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.25

Absci MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
86.5% Upside
$9.25 Price Target
Short Interest
Healthy
7.96% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.77mentions of Absci in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$13.64 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.80) to ($0.65) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.54 out of 5 stars

Medical Sector

443rd out of 913 stocks

Commercial Physical Research Industry

7th out of 11 stocks

ABSI stock logo

About Absci Stock (NASDAQ:ABSI)

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.

ABSI Stock Price History

ABSI Stock News Headlines

Absci Corporation (ABSI)
Absci: Q4 Earnings Insights
ABSI Apr 2024 6.000 call
TD Cowen Keeps Their Buy Rating on AbSci (ABSI)
Why Absci (ABSI) Shares Are Falling
Absci Announces Pricing of Public Offering of Common Stock
Absci Announces Proposed Public Offering of Common Stock
See More Headlines
Receive ABSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Absci and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/13/2024
Today
6/12/2024
Next Earnings (Estimated)
8/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:ABSI
Fax
N/A
Employees
155
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$9.25
High Stock Price Target
$13.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+86.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-110,570,000.00
Net Margins
-2,042.01%
Pretax Margin
-2,040.04%

Debt

Sales & Book Value

Annual Sales
$5.72 million
Book Value
$1.90 per share

Miscellaneous

Free Float
101,990,000
Market Cap
$560.88 million
Optionable
Optionable
Beta
2.29
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives


ABSI Stock Analysis - Frequently Asked Questions

Should I buy or sell Absci stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Absci in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ABSI shares.
View ABSI analyst ratings
or view top-rated stocks.

What is Absci's stock price target for 2024?

4 equities research analysts have issued 1-year price objectives for Absci's shares. Their ABSI share price targets range from $7.00 to $13.00. On average, they expect the company's stock price to reach $9.25 in the next twelve months. This suggests a possible upside of 86.5% from the stock's current price.
View analysts price targets for ABSI
or view top-rated stocks among Wall Street analysts.

How have ABSI shares performed in 2024?

Absci's stock was trading at $4.20 at the beginning of 2024. Since then, ABSI shares have increased by 18.1% and is now trading at $4.96.
View the best growth stocks for 2024 here
.

Are investors shorting Absci?

Absci saw a drop in short interest during the month of May. As of May 31st, there was short interest totaling 7,290,000 shares, a drop of 5.6% from the May 15th total of 7,720,000 shares. Based on an average trading volume of 1,120,000 shares, the days-to-cover ratio is presently 6.5 days. Approximately 8.0% of the company's stock are sold short.
View Absci's Short Interest
.

When is Absci's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 12th 2024.
View our ABSI earnings forecast
.

How were Absci's earnings last quarter?

Absci Co. (NASDAQ:ABSI) issued its quarterly earnings data on Monday, May, 13th. The company reported ($0.22) earnings per share for the quarter, missing analysts' consensus estimates of ($0.19) by $0.03. The company earned $0.90 million during the quarter, compared to analysts' expectations of $2.50 million. Absci had a negative trailing twelve-month return on equity of 44.60% and a negative net margin of 2,042.01%. During the same quarter in the prior year, the business earned ($0.26) earnings per share.

What ETF holds Absci's stock?

ARK Genomic Revolution ETF holds 4,076,421 shares of ABSI stock, representing 1.24% of its portfolio.

When did Absci IPO?

Absci (ABSI) raised $200 million in an initial public offering on Thursday, July 22nd 2021. The company issued 12,500,000 shares at $15.00-$17.00 per share.

Who are Absci's major shareholders?

Absci's stock is owned by a variety of institutional and retail investors. Top institutional investors include Redmile Group LLC (7.30%), Vanguard Group Inc. (3.05%), Affinity Asset Advisors LLC (0.91%), Platinum Investment Management Ltd. (0.69%), Sumitomo Mitsui Trust Holdings Inc. (0.37%) and Nikko Asset Management Americas Inc. (0.37%). Insiders that own company stock include Karen K Mcginnis, Phoenix Venture Partners Ii Lp, Redmile Group, Llc, Sarah Korman, Sean Mcclain and Todd Bedrick.
View institutional ownership trends
.

How do I buy shares of Absci?

Shares of ABSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ABSI) was last updated on 6/13/2024 by MarketBeat.com Staff

From Our Partners